Home
This page may not work correctly in your current browser, Internet Explorer. We recommend changing to a more modern browser before viewing this page. We recommend
Chrome
,
Firefox
,
Safari
, or
Edge
.
Member Directory
- Details for Company Member
Company Name:
Inhibikase Therapeutics
Company Contact:
Milton Werner
City:
Atlanta
State/Province:
GA
Web Site:
http://www.inhibikase.com
Member Type:
Core (Life Sciences Company)
Categories:
Testing Laboratories | Clinical
Description:
Inhibikase is a clinical-stage specialty pharmaceutical company focused on developing and commercializing small-molecule kinase inhibitor therapeutics for the safe and effective treatment of CNS diseases, including diseases of the brain.
Our proprietary RAMP (Re-engineering Approach with Metabolism Preserved) drug innovation engine enables us to design and develop novel small-molecule product candidates that leverage the clinical experience gained from currently marketed kinase inhibitor drugs that target non-CNS diseases. Using this established knowledge as a starting point, we pursue the clinically validated kinases as targets for the creation of novel drugs with enhanced efficacy and improved safety that may be administered chronically and systemically to treat kinase inhibitor-sensitive CNS diseases.